<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="4" ids="30225">Positron</z:chebi> emission tomography (PET) was used to measure cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO2), and cerebral metabolic rate of <z:chebi fb="105" ids="17234">glucose</z:chebi> (CMRglc) in patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In the patients, values for CBF, CMRO2, and CMRglc have been shown to drop by 30-50% in comparison to age-matched <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="2" pm="."><plain>In the early stage (stage I), reductions in CBF and CMRO2 are prominent in the temporal and the temporoparietal cortices </plain></SENT>
<SENT sid="3" pm="."><plain>In stage II, reduction in the parietal cortex also become quite prominent, and in the late stage (stage III) reduction begins prominently in the frontal cortex as well </plain></SENT>
<SENT sid="4" pm="."><plain>These PET findings in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> differ from those in vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, <z:e sem="disease" ids="C0236642" disease_type="Disease or Syndrome" abbrv="">Pick's disease</z:e>, and <z:e sem="disease" ids="C0020179" disease_type="Disease or Syndrome" abbrv="HD">Huntington's disease</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In the interrelationship among CBF, CMRO2 and higher brain function, CBF and CMRO2 decrease especially in the left frontal, the left temporal and the left parietal cortices in patients with marked <z:e sem="disease" ids="C0023015" disease_type="Mental or Behavioral Dysfunction" abbrv="">language disability</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>On the contrary, CBF and CMRO2 decrease in the right temporal and the right parietal cortices in patients with marked <z:hpo ids='HP_0002186'>apraxia</z:hpo> and visuospatial deficits </plain></SENT>
<SENT sid="7" pm="."><plain>Cerebral blood flow and metabolism are closely related to the functioning of nerve cells </plain></SENT>
<SENT sid="8" pm="."><plain>Therefore we can isolate the region responsible for higher <z:e sem="disease" ids="C0262405" disease_type="Disease or Syndrome" abbrv="">brain dysfunction</z:e> and similarly evaluate the effects of treatment using cerebral blood flow and metabolism measurements </plain></SENT>
</text></document>